Target intelligence / Profile preview

Neutrophil (activated state)

Molecular classification
Other (Terminally differentiated myeloid cell), Immune cell, Effector cell of innate immunity
01

Overview

Activated neutrophils are terminally differentiated white blood cells that play a central role as effector cells within the innate immune system. Upon activation by infection-, injury-, or cytokine-derived signals—including chemokines like IL‑8—they rapidly migrate from the bloodstream into tissues where they execute multiple antimicrobial functions. These include phagocytosis; degranulation with release of proteases and antimicrobial peptides; generation of reactive oxygen species; secretion of pro-inflammatory mediators; and formation/release of web-like structures called neutrophil extracellular traps (NETs), which immobilize pathogens but can also contribute to tissue damage if dysregulated. Activated neutrophils are implicated not only in host defense against bacteria/fungi but also play complex roles—both protective and pathogenic—in inflammatory diseases such as sepsis, autoimmune disorders, cardiovascular disease/thrombosis via NETs formation, chronic lung conditions like COPD/asthma/bronchiectasis where their overactivity drives pathology. In oncology settings they may either suppress tumor immunity/promote metastasis (“pro-tumoral” N2 phenotype) or exert cytotoxic anti-tumoral effects (“anti-tumoral” N1 phenotype). Therapeutic strategies target their recruitment/mobilization from bone marrow using agents like G-CSF for immunostimulation or CXCR4 antagonists for mobilizing leukemic cells. Drugs that modulate their activation state—including macrolide antibiotics—are being explored especially where excessive NET production contributes to disease severity.

Other names
Activated neutrophilPolymorphonuclear leukocyte (activated)PMN (activated)Inflammatory neutrophil
02

Mechanism of action

– Stimulation or inhibition of activation pathways including chemokine receptor signaling, ROS production, degranulation, NETosis – Mobilization from bone marrow by disrupting retention signals like CXCL12-CXCR4 axis – Modulation/inhibition of pro-inflammatory functions with anti-inflammatory drugs or targeted nanomedicines

03

Biological functions

Immune responsePhagocytosisDegranulation/release of antimicrobial proteinsProduction of reactive oxygen species (ROS)Formation of neutrophil extracellular traps (NETs)Chemotaxis/migration to sites of inflammation or infection
04

Disease associations

Infection/host defense against pathogensInflammation and inflammatory diseases, including autoimmune disorders and acute tissue injuryCancer/tumor progression or suppression, depending on context ("tumor-associated neutrophils")Cardiovascular disease/thrombosis/atherosclerosis via NETs and inflammation
05

Safety considerations

Overactivation can drive excessive inflammation leading to tissue damage ("cytokine storm," ARDS) or autoimmunity; implicated in sepsis pathogenesis and organ failure due to uncontrolled NET release/inflammationDual role in cancer: may promote tumor growth/metastasis via immunosuppression/angiogenesis but also mediate anti-tumor effects depending on microenvironment/context ("double-edged sword")
06

Interacting drugs

Granulocyte colony-stimulating factor (G-CSF; e.g., filgrastim)

2 more in the full profile.

07

Biomarkers

Surface markers such as CD11b, CD15, CD16, CD66b used to identify activated human neutrophils and subsets like PMN-MDSCs in cancer/inflammation contextsNeutrophil extracellular trap components/DNA-protein complexes as biomarkers for disease severity in bronchiectasis/asthma/COPD/sepsisNeutrophil-to-Lymphocyte Ratio (NLR) is a prognostic biomarker in cancer/glioma patients reflecting systemic inflammation/neutrophilia

Beyond the preview

Go deeper on Neutrophil (activated state).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neutrophil (activated state).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call